Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CryoPort
CYRX
$762M
| $69K | ﹤0.01% |
2,235
-6,088
| -73% | -$162K |
|
3752
Hamilton Beach Brands
HBB
$422M
| $69K | ﹤0.01% |
5,551
-1,206
| -18% | -$12.7K |
|
3753
Huron Consulting
HURN
$2.42B
| $69K | ﹤0.01% |
1,055
-2,570
| -71% | -$145K |
|
|
HRT
3754
DELISTED
HireRight Holdings Corporation
HRT
| $69K | ﹤0.01% |
4,864
-6,745
| -58% | -$105K |
|
|
CLVS
3755
DELISTED
Clovis Oncology, Inc.
CLVS
| $69K | ﹤0.01% |
38,408
-37,866
| -50% | -$55.9K |
|
|
SRTA
3756
Strata Critical Medical Inc
SRTA
$512M
| $68K | ﹤0.01% |
15,307
+3,312
| +28% | +$23.9K |
|
3757
4D Molecular Therapeutics
FDMT
$562M
| $68K | ﹤0.01% |
9,616
-2,340
| -20% | -$22.7K |
|
3758
IBEX
IBEX
$499M
| $68K | ﹤0.01% |
3,990
-858
| -18% | -$14K |
|
3759
iShares Cybersecurity and Tech ETF
IHAK
$1.1B
| $68K | ﹤0.01% |
1,941
| – | – |
|
|
DNMR
3760
DELISTED
Danimer Scientific, Inc.
DNMR
| $68K | ﹤0.01% |
370
-286
| -44% | -$52K |
|
|
ALLG
3761
DELISTED
Allego N.V.
ALLG
| $68K | ﹤0.01% |
+13,406
| New | +$123K |
|
|
PSPC
3762
DELISTED
Post Holdings Partnering Corporation
PSPC
| $68K | ﹤0.01% |
+7,036
| New | +$68.5K |
|
3763
Mission Produce
AVO
$1.17B
| $67K | ﹤0.01% |
4,653
-4,075
| -47% | -$54.4K |
|
3764
Identive
INVE
$61.9M
| $67K | ﹤0.01% |
5,769
-2,383
| -29% | -$29.8K |
|
3765
MannKind Corp
MNKD
$1.32B
| $67K | ﹤0.01% |
17,413
-23,772
| -58% | -$87.3K |
|
3766
PureCycle Technologies
PCT
$1.45B
| $67K | ﹤0.01% |
9,013
-4,315
| -32% | -$36.1K |
|
3767
Shattuck Labs
STTK
$694M
| $67K | ﹤0.01% |
16,510
-4,350
| -21% | -$15.8K |
|
|
OBSV
3768
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $67K | ﹤0.01% |
41,624
+338
| +0.8% | +$558 |
|
|
IVC
3769
DELISTED
Invacare Corporation
IVC
| $67K | ﹤0.01% |
52,737
+37,535
| +247% | +$49.4K |
|
|
SMED
3770
DELISTED
Sharps Compliance Corp
SMED
| $67K | ﹤0.01% |
22,845
-3,053
| -12% | -$12.7K |
|
3771
Cimpress
CMPR
$2.31B
| $66K | ﹤0.01% |
1,718
-2,199
| -56% | -$107K |
|
3772
Equinox Gold
EQX
$13.5B
| $66K | ﹤0.01% |
14,831
| – | – |
|
3773
Ocular Therapeutix
OCUL
$2.02B
| $66K | ﹤0.01% |
16,369
-16,112
| -50% | -$60.9K |
|
3774
Powell Industries
POWL
$7.71B
| $66K | ﹤0.01% |
8,487
-13,335
| -61% | -$104K |
|
3775
Perimeter Solutions
PRM
$5.77B
| $66K | ﹤0.01% |
+6,116
| New | +$65.2K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.